We recently reported IL-5, IL-10, IL-6, CxCL-10, and TGF-β elevation in both participants with EpKS and EnKS when compared to KSHV-infected asymptomatic controls prior to cancer therapy [25]. This evidence concerns the gene IL6 and cancer.